Nemaura Medical Inc. (NASDAQ: NMRD) Helping Diabetic Individuals Safeguard Themselves From COVID-19
1 in 8 adults are forecast to suffer from diabetes by 2024, with over 1 in 10 deaths in 2021 a direct result of the disease As many as 40% of Covid-19 related fatalities in the US also suffered from diabetes at the time of their passing Nemaura Medical is a medical technology company focused on developing non-invasive wearable diagnostic devices In addition to sugarBEAT, its flagship device, the company also recently announced the launch of MiBoKo, a combined application and non-invasive glucose sensor designed to help users track their metabolic scores By 2024, the International Diabetes Federation (“IDF”) predicts…